Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Rusan Pharma aims Rs 600-crore revenues in 2-3 years

      Rusan Pharma aims Rs 600-crore revenues in 2-3 years

      Ruby Khatun Khatun5 Jun 2017 9:26 AM IST
      Rusan Pharma, which specialises in pain management, opioid de-addiction & anti-infectives therapies, on Thursday said it aims to generate revenues...
      Mankind Pharma Partners With Smile Train India to Provide Free Cleft Surgeries to 100 Children

      Mankind Pharma Partners With Smile Train India to Provide Free Cleft Surgeries to 100 Children

      Ruby Khatun Khatun4 Jun 2017 11:00 AM IST
      New Delhi: Mankind Pharma Ltd., one of India's fastest growing pharmaceutical companies, announced a partnership with Smile Train India, the world's...
      Cholamandalam MS General Insurance raises Rs 100 cr via bonds

      Cholamandalam MS General Insurance raises Rs 100 cr via bonds

      Ruby Khatun Khatun4 Jun 2017 9:50 AM IST
      New Delhi: Cholamandalam MS General Insurance Company has raised Rs 100 crore by floating bonds on a private placement basis.The company issued 1,000...
      Zydus Cadila gets USFDA nod for levofloxacin injection

      Zydus Cadila gets USFDA nod for levofloxacin injection

      Ruby Khatun Khatun4 Jun 2017 9:48 AM IST
      New Delhi: Drug firm Zydus Cadila has received the US health regulator's nod to market levofloxacin injection, used to treat bacterial infections, in...
      Pfizer defeats appeals linking Zoloft to birth defects

      Pfizer defeats appeals linking Zoloft to birth defects

      Ruby Khatun Khatun4 Jun 2017 9:44 AM IST
      Pfizer Inc on Friday defeated an effort to revive more than 300 lawsuits alleging that its antidepressant Zoloft causes cardiac birth defects in...
      CEO Richard P. Goudis Transitions to New Role as Herbalife Nutrition CEO

      CEO Richard P. Goudis Transitions to New Role as Herbalife Nutrition CEO

      Ruby Khatun Khatun4 Jun 2017 9:41 AM IST
      LOS ANGELES: Premier global nutrition company, Herbalife, announced the official transition of Richard P. Goudis as the new Chief Executive Officer...
      Pfizer hiked US prices of 91 drugs by average 20 percent in 2017: Financial Times

      Pfizer hiked US prices of 91 drugs by average 20 percent in 2017: Financial Times

      Ruby Khatun Khatun4 Jun 2017 9:41 AM IST
      Pfizer Inc has hiked the price of nearly a hundred drugs by an average of 20 percent so far this year in the United States, the Financial Times...
      Elder Pharma files for insolvency

      Elder Pharma files for insolvency

      Ruby Khatun Khatun3 Jun 2017 3:00 PM IST
      Elder Pharmaceuticals has filed for insolvency, in an attempt to restructure its debt, according to a source .The Company began disintegrating after...
      Strides Shasun gets USFDA nod for pain reliever drug

      Strides Shasun gets USFDA nod for pain reliever drug

      Ruby Khatun Khatun3 Jun 2017 10:27 AM IST
      New Delhi: Strides Shasun has got approval from the US health regulator for pain reliever drug ibuprofen.The product will be marketed by Strides...
      Medical device industry seeks ease of doing business

      Medical device industry seeks ease of doing business

      Ruby Khatun Khatun3 Jun 2017 10:17 AM IST
      New Delhi: Government needs to create health infrastructure and come out with a law separating medical devices from drugs before it pushes the...
      Vanrx Pharmasystems appoints Shreedhar Instruments as its distributor in India

      Vanrx Pharmasystems appoints Shreedhar Instruments as its distributor in India

      Ruby Khatun Khatun3 Jun 2017 9:50 AM IST
      VANCOUVER, British Columbia: Vanrx Pharmasystems, a manufacturer of advanced aseptic filling systems for the pharmaceutical industry, has announced...
      Aurobindo Pharma Q4 Net dips 4% to Rs 532 crore

      Aurobindo Pharma Q4 Net dips 4% to Rs 532 crore

      Ruby Khatun Khatun3 Jun 2017 9:30 AM IST
      New Delhi: Aurobindo Pharma posted a 4 per cent dip in consolidated net profit at Rs 532.22 crore for the fourth quarter ended March 2017.The company...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok